Supplementary Online Content

Size: px
Start display at page:

Download "Supplementary Online Content"

Transcription

1 Supplementary Online Content Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patientlevel data. Published online June 23, JAMA Intern Med. doi: /jamainternmed emethods. etable 1. CRT-D to ICD Hazard Ratios for Outcomes by Sex in the Total Population etable 2. CRT-D to ICD Hazard Ratios for Heart Failure or Death in LBBB QRS Duration Intervals by Sex etable 3. CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and Multivariable Adjusted Analysis by Sex efigure 1. CRT-D to ICD Hazard Ratios for Outcomes in non-lbbb QRS<150 and 150 ms Groups by Sex efigure 2. Kaplan-Meier Estimates of Heart Failure or Death in LBBB Stratified by Sex in QRS and 150 ms efigure 3. Kaplan-Meier Estimates of Death in LBBB Stratified by Sex in QRS and 150 ms efigure 4. Smoothed Spline Analysis for Women and Men with LBBB using QRS Duration as a Continuous Variable efigure 5. CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and NYHA I/II Analysis by Sex ereferences. This supplementary material has been provided by the authors to give readers additional information about their work American Medical Association. All rights reserved.

2 Supplementary Appendix Cardiac Resynchronization Therapy in Women: FDA Meta-Analysis of Patient-Level Data Table of contents: emethods etable 1: CRT-D to ICD Hazard Ratios for Outcomes by Sex in the Total Population efigure 1: CRT-D to ICD Hazard Ratios for Outcomes in non-lbbb QRS<150 and 150 ms Groups by Sex etable 2: CRT-D to ICD Hazard Ratios for Heart Failure or Death in LBBB QRS Duration Intervals by Sex efigure 2: Kaplan-Meier Estimates of Heart Failure or Death in LBBB Stratified by Sex in QRS and 150 ms efigure 3: Kaplan-Meier Estimates of Death in LBBB Stratified by Sex in QRS and 150 ms efigure 4: Smoothed Spline Analysis for Women and Men with LBBB using QRS Duration as a Continuous Variable etable 3: CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and Multivariable Adjusted Analysis by Sex efigure 5: CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and NYHA I/II Analysis by Sex ereferences 2

3 emethods R Commands for Calculating Random Intercept Models for CRT-D Effect Across Trials The coxme library for R was used to determine random effects. 1,2 The following model codes were used: 1. Determining sex-by-treatment interactions in random intercepts for CRT-D effect across trials by subgroups: library(coxme); coxme(formula = Surv(time-to-event, event) a ~ treatment b + sex c + sex-by-treatment interaction d + (1 trial) e, data = data f ) 2. Determining random intercepts for CRT-D effect across trials in women and men by subgroups: library(coxme); coxme(formula = Surv(time-to-event, event) a ~ treatment b + (1 trial) c, data = data d ) a Time-to-event and event include one of either end points (heart failure event or death and death alone) b Treatment includes the CRT-D vs. ICD variable for all models c Sex includes either female or male d Sex-by-treatment interaction includes the sex variable multiplied by the treatment variable e Indicates the random intercept per trial f Data includes the specific subgroups for women and men separately (total database, LBBB, non-lbbb, QRS <150 ms, QRS 150 ms, ischemic heart failure etiology, non-ischemic heart failure etiology, LBBB , LBBB , LBBB , LBBB , LBBB , LBBB , LBBB 180, LBBB , LBBB 150) 3

4 etable 1. CRT-D to ICD Hazard Ratios for Outcomes by Sex in the Total Population Total population Women 0.40 Men 0.74 Left bundle branch block Women 0.33 Men 0.60 Non-Left bundle branch block Women 1.02 Men 1.12 QRS duration >150 Women 0.37 Men 0.56 QRS duration <150 Women 0.46 Men 1.09 Ischemic heart disease Women 0.55 Men 0.70 Non-ischemic heart disease Women 0.32 Men 0.79 Hazard Ratio (95% CI) P-value Heart Failure Interactio or Death n Hazard Ratio (95% CI) Death ( ) ( ) 0.85 ( ) ( ) 0.68 ( ) ( ) 1.21 ( ) ( ) 0.71 ( ) ( ) 1.03 ( ) ( ) 0.87 ( ) ( ) 0.70 P-value Interactio n ( ) 0.03 ( ) ( ) 0.08 ( ) ( ) 0.58 ( ) ( ) 0.11 ( ) ( ) 0.15 ( ) ( ) 0.22 ( ) ( ) 0.22 ( ) CRT-D to ICD hazard ratios including 95% confidence intervals for heart failure event or death (left) and for death alone (right) in subgroups separately in women and men. P-values represent sex-by-treatment interactions. This is the same information that is displayed in Figure 1. 4

5 efigure 1. CRT-D to ICD Hazard Ratios for Outcomes in non-lbbb QRS<150 and 150 ms Groups by Sex Points reflect CRT-D to ICD hazard ratios for heart failure event or death (left) and for death alone (middle) in subgroups separately in women and men for non-lbbb patients. Solid lines indicate 95% confidence intervals. P-values represent sex-by-treatment interactions. Number of events and total subjects are listed for each subgroup. 5

6 etable 2. CRT-D to ICD Hazard Ratios for Heart Failure Event or Death in LBBB QRS Duration Intervals by Sex Hazard Ratio (95% CI) QRS duration Heart Failure or Death intervals (ms) Women Men ( ) 1.49 ( ) ( ) 0.77 ( ) ( ) 0.92 ( ) ( ) 0.56 ( ) ( ) 0.41 ( ) ( ) 0.51 ( ) ( ) 0.44 ( ) CRT-D to ICD hazard ratios including 95% confidence intervals for heart failure event or death in women (left) and men (right) across QRS duration intervals. 6

7 efigure 2: Kaplan-Meier Estimates of Heart Failure or Death in LBBB Stratified by Sex in QRS and 150 ms Curves reflect the probability of heart failure event or death in women (left) and men (right) with CRT-D (solid line) or ICD (dotted line) in QRS duration (top) and 150 ms (bottom). Log rank P-values are listed on each graph. The number of patients remaining (and event rate) is listed at each year of follow-up. 7

8 efigure 3: Kaplan-Meier Estimates of Death in LBBB Stratified by Sex in QRS and 150 ms Curves reflect the probability of death in women (left) and men (right) with CRT-D (solid line) or ICD (dotted line) in QRS duration (top) and 150 ms (bottom). Log rank P-values are listed on each graph. The number of patients remaining (and event rate) is listed at each year of follow-up. 8

9 efigure 4: Smoothed Spline Analysis for Women and Men with LBBB using QRS Duration as a Continuous Variable Curves reflect the CRT-D to ICD hazard ratio (blue) and 95% confidence intervals (red) for heart failure event or death in women (left) and men (right) with left bundle branch block using QRS duration as a continuous variable. The black horizontal line indicates hazard ratio = 1. 9

10 etable 3. CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and Multivariable Adjusted Analysis by Sex QRS Duration Group ms Hazard Ratio (95% CI) Heart Failure or Death P- value Interac tion Hazard Ratio (95% CI) Death P- value Interac tion Main Women 0.64 ( ) ( ) 0.92 Men 1.49 ( ) 0.76 ( ) Women N/A N/A N/A N/A N/A N/A Multivari ( able Men ) N/A N/A ms Main Women 0.24 Multivari able Men 0.85 Women 0.23 Men ms Main Women 0.33 Multivari able Men 0.47 Women 0.33 Men 0.44 ( ) ( ) 0.86 ( ) ( ) 0.90 ( ) ( ) 0.65 ( ) ( ) 0.62 ( ) ( ) ( ) ( ) ( ) 0.20 ( ) ( ) 0.22 ( ) CRT-D to ICD hazard ratios including 95% confidence intervals for heart failure event or death (left) and for death alone (right) in subgroups separately in women and men for the main and multivariable adjusted analysis. P-values represent sex-by-treatment interactions. This is the same information that is displayed in Figure 3. 10

11 efigure 5. CRT-D to ICD Hazard Ratios for Outcomes in LBBB and QRS Duration Groups of Main and NYHA I/II Analysis by Sex Points reflect CRT-D to ICD hazard ratios for heart failure event or death (left) and for death alone (middle) in subgroups separately in women and men for the main analysis and NYHA class I and II patients. Solid lines indicate 95% confidence intervals. P-values represent sex-by-treatment interactions. Number of events and total subjects are listed for each subgroup. 11

12 ereferences 1. R: A Language and Environment for Statistical Computing. 2013; Accessed April 15, Package coxme for R. 2013; Accessed April 15,

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B 1. JAMA. 9;3(19):119-1. etable 1. Circulating Levels of B

More information

It has been shown from meta-analysis of randomized clinical trials that patients with a pre-crt QRS duration (QRSD) >150 ms benefit

It has been shown from meta-analysis of randomized clinical trials that patients with a pre-crt QRS duration (QRSD) >150 ms benefit Cardiac Resynchronization Therapy may be detrimental in patients with a Very Wide QRSD > 180 ms (VWQRSD) and Right Bundle Branch Block Morphology: Analysis From the Medicare ICD Registry Varun Sundaram

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Jänne PA, van den Heuvel MM, Barlesi F, et al. Effect of selumetinib plus docetaxel compared with docetaxel alone and progression-free survival in patients with KRASmutant

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Giannakeas V, Sopik V, Narod SA. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy. JAMA Netw Open. 2018;1(4):e181100.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Nikolova AP, Hitzeman TC, Baum R, et al. Association of a novel diagnostic biomarker, the plasma cardiac bridging integrator 1 score, with heart failure with preserved ejection

More information

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure HOT TOPIC Cardiology Journal 2010, Vol. 17, No. 6, pp. 543 548 Copyright 2010 Via Medica ISSN 1897 5593 Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sussman JB, Kerr EA, Saini SD, et al. Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group. Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes:

More information

The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy

The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy The Role of Ventricular Electrical Delay to Predict Left Ventricular Remodeling With Cardiac Resynchronization Therapy Results from the SMART-AV Trial Michael R. Gold, MD, PhD, Ulrika Birgersdotter-Green,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Wahbi K, Meune C, Porcher R, et al. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease. JAMA.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

Large RCT s of CRT 2002 to present

Large RCT s of CRT 2002 to present Have We Expanded Our Use of CRT for Heart Failure Patients? Sana M. Al-Khatib, MD, MHS Associate Professor of Medicine Electrophysiology Section- Division of Cardiology Duke University Potential Conflicts

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553-1559. eequation. Applying the

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lingvay I, Manghi FP, García-Hernández P, et al. Effect of insulin glargine up-titration vs insulin degludec/liraglutide on glycated hemoglobin levels in patients with type

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content El-Sadr WM, Donnell D, Beauchamp G, et al. Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065)

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.

More information

The Role of ICD Therapy in Cardiac Resynchronization

The Role of ICD Therapy in Cardiac Resynchronization The Role of ICD Therapy in Cardiac Resynchronization The Korean Society of Circulation 15 April 2005 Angel R. León, MD Carlyle Fraser Heart Center Division of Cardiology Emory University School of Medicine

More information

Cardiac Resynchronization ICD Therapy: What is New?

Cardiac Resynchronization ICD Therapy: What is New? Cardiac Resynchronization ICD Therapy: What is New? Emile Daoud, MD Section Chief, Cardiac Electrophysiology Professor of Medicine The Ohio State University Normal Activation, Narrow QRS Synchrony Abnormal

More information

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy Electrophysiology Gender and cardiac resynchronization therapy Dean Boddington Chairs: David Heaven & Belinda Green Gender and Cardiac Resynchronisation Therapy Dean Boddington Tauranga Hospital 1 Disclosure/Warning

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Song Z, Ayanian JZ, Wallace J, He Y, Gibson TB, Chernew ME. Unintended consequences of eliminating Medicare payments for consultations. JAMA Intern Med. Published online November

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Acuna SA, Fernandes KA, Daly C, et al. Cancer mortality among recipients of solidorgan transplantation in Ontario, Canada. JAMA Oncol. Published online January 7, 2016. doi:10.1001/jamaoncol.2015.5137

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Viktorin A, Uher R, Kolevzon A, Reichenberg A, Levine SZ, Sandin S. Association of antidepressant medication use during pregnancy with intellectual disability in offspring.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Uranga A, España, Bilbao A, et al. Duration of antibiotic treatment in communityacquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. ublished online

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Gershengorn HB, Scales DC, Kramer A, Wunsch H. Association between overnight extubations and outcomes in the intensive care unit. JAMA Intern Med. Published online September

More information

Online Appendix (JACC )

Online Appendix (JACC ) Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287

More information

CRT Vs RV Pacing Benefits

CRT Vs RV Pacing Benefits CRT-P & CRT-D Indications According to Guidelines are Guidelines Fully Adopted? Salama H. Omar M.D. Prof. Critical Care Medicine, Cairo University CRT Vs RV Pacing Benefits 1 Benefit of Upgrade CTR-P &

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: Consulting and Clinical Trials Medtronic

More information

Supplementary Appendix to manuscript submitted by Trappe, R.U. et al:

Supplementary Appendix to manuscript submitted by Trappe, R.U. et al: Supplementary Appendix to manuscript submitted by Trappe, R.U. et al: Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Marklund M, Carlberg B, Forsgren L, Olsson T, Stenlund H, Franklin KA. Oral appliance therapy in patients with daytime sleepiness and snoring or mild to moderate sleep apnea:

More information

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide Supplementary Online Content Yao S, Kuja-Halkola R, Thornton LM, et al. Familial liability for eating s and suicide attempts: evidence from a population registry in Sweden. JAMA Psychiatry. Published online

More information

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block Yitschak Biton, MD; Wojciech Zareba, MD, PhD; Ilan Goldenberg,

More information

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content McCaul KA, Lawrence-Brown M, Dickinson JA, Norman PE. Long-term outcomes of the Western Australian trial of screening for abdominal aortic aneurysms: secondary analysis of

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Shurraw S, Hemmelgarn B, Lin M, et al. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Basaria S, Harman SM, Travison TG, et al. The effects of testosterone administration for three years on subclinical atherosclerosis progression in older men with low or low

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Verma A, Champagne J, Sapp J, et al. Asymptomatic episodes of atrial fibrillation before and after catheter ablation: a prospective, multicenter study. JAMA Intern Med. Published

More information

2017 American Medical Association. All rights reserved.

2017 American Medical Association. All rights reserved. Supplementary Online Content Borocas DA, Alvarez J, Resnick MJ, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content The Premenopausal Breast Cancer Collaborative Group. Association body mass index and age with premenopausal breast cancer risk in premenopausal women. JAMA Oncol. Published

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Malik S, Zhao Y, Budoff M, et al. Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic

More information

Biostatistics II

Biostatistics II Biostatistics II 514-5509 Course Description: Modern multivariable statistical analysis based on the concept of generalized linear models. Includes linear, logistic, and Poisson regression, survival analysis,

More information

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure The new england journal of medicine original article Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure Ilan Goldenberg, M.D., Valentina Kutyifa, M.D., Ph.D., Helmut U. Klein, M.D.,

More information

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure Journal of the American College of Cardiology Vol. 60, No. 19, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.054

More information

Supplementary Online Content 2

Supplementary Online Content 2 Supplementary Online Content 2 Bieleninik Ł, Geretsegger M, Mössler K, et al; TIME-A Study Team. Effects of improvisational music therapy vs enhanced standard care on symptom severity among children with

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Lu Y, Sjölander A, Cederlöf M, et al. Association between medication use and performance on higher education entrance tests in individuals with attentiondeficit/hyperactivity

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Karagas MR, Punshon T, Sayarath V, Jackson BP, Folt CL, Cottingham KL. Association of rice and rice-product consumption with arsenic exposure early in life. JAMA Pediatr. Published

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Rollman BL, Herbeck Belnap B, Abebe KZ, et al. Effectiveness of online collaborative care for treating mood and anxiety disorders in primary care: a randomized clinical trial.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Cooper DJ, Nichol A, Bailey M, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Chahal HS, Marseille EA, Tice JA, et al. Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population.

More information

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11

Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias. Markus Kowalsky Group 11 Evaluation of Sum Absolute QRST Integral as a Clinical Marker for Ventricular Arrhythmias Markus Kowalsky Group 11 Selected Paper Ventricular arrhythmia is predicted by sum absolute QRST integral but not

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content James MT, Neesh P, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. doi:10.1001/jama.2017.16326

More information

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure Last Review Status/Date: June 2015 Page: 1 of 29 Resynchronization Therapy) for the Treatment Description Cardiac resynchronization therapy (CRT), which consists of synchronized pacing of the left and

More information

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure Biventricular Pacemakers (Cardiac Resynchronization Therapy for the Treatment of Heart Failure 2.02.10 Biventricular Pacemakers (Cardiac Resynchronization Therapy for the Treatment of Heart Failure Policy

More information

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Do All Patients With An ICD Indication Need A BiV Pacing Device? Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology

More information

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure

Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure Last Review Status/Date: September 2016 Page: 1 of 29 Resynchronization Therapy) for the Treatment Description Cardiac resynchronization therapy (CRT), which consists of synchronized pacing of the left

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kappos L, Li DKB, Stüve O, et al. Safety and efficacy of siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis: dose-blinded, randomized extension of the

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Callaghan B, McCammon R, Kerber K, Xu X, Langa KM, Feldman E. Tests and expenditures in the initial evaluation of peripheral neuropathy. Arch Intern Med. 2012;172(2):127-132.

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schmidt B, Whyte RK, Asztalos EV, et al; for the Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Schnabel RB, Aspelund T, Li G, et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med. 2010;170(21):1909-1917. eappendix.

More information

Prognostic Value of Left Ventricular Dyssynchrony by Phase Analysis of Gated SPECT in Patients Undergoing Myocardial Perfusion Imaging

Prognostic Value of Left Ventricular Dyssynchrony by Phase Analysis of Gated SPECT in Patients Undergoing Myocardial Perfusion Imaging Prognostic Value of Left Ventricular Dyssynchrony by Phase Analysis of Gated SPECT in Patients Undergoing Myocardial Perfusion Imaging Nili Zafrir, Tamir Bental, Ariel Gutstein, Israel Mats, Doron Belzer,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mølgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA. 2011;305(19):1996-2002. emethods. Birth defects and potential confounders

More information

JACC: Heart Failure Vol. 1, No. 3, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN /$36.00

JACC: Heart Failure Vol. 1, No. 3, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN /$36.00 JACC: Heart Failure Vol. 1, No. 3, 2013 Ó 2013 by the American College of Cardiology Foundation ISSN 2213-1779/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jchf.2013.03.005 Left Bundle

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Neuhouser ML, Aragaki AK, Prentice RL, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the Women s Health Initiative randomized

More information

Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT

Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT Heart Rhythm Society (May 11, 2012) Colin L. Doyle, BA,*

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Douxfils J, Haguet H, Mullier F, Chatelain C, Graux C, Dogné J-M. Use of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and metaanalysis

More information

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, MD, FHRS

Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, MD, FHRS Biomarkers and Arrhythmias/Devices Ulrika Birgersdotter-Green, MD, FHRS Professor of Medicine Division of Cardiology University of California, San Diego Disclosures Honoraria, Research Grants, Medtronic

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Berhane K, Chang C-C, McConnell R, et al. Association of changes in air quality with bronchitic symptoms in children in California, 1993-2012. JAMA. doi:10.1001/jama.2016.3444

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. Published online February

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA. doi:10.1001/jama.2014.8266

More information

Guideline-Directed Medical Therapy

Guideline-Directed Medical Therapy Guideline-Directed Medical Therapy Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation OPTIMAL THERAPY (As defined in

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Peters PJ, Westheimer E, Cohen S, et al. Screening yield of HIV antigen/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population.

More information

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association between androgen deprivation therapy and risk of dementia. JAMA Oncol. Published online October

More information

Prognostic Implication of the QRS Axis and its Association with Myocardial Scarring in Patients with Left Bundle Branch Block

Prognostic Implication of the QRS Axis and its Association with Myocardial Scarring in Patients with Left Bundle Branch Block Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Prognostic Implication of the QRS Axis and its Association with Myocardial Scarring in Patients with Left Bundle

More information

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER ICD for NICM All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, 2017 2017 MFMER 3686275-1 DISCLOSURE Relevant Financial Relationship(s)

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Mezquita L, Auclin E, Ferrara R, et al. Association of the Lung Immune Prognostic Index with immune checkpoint inhibitor outcomes in patients with advanced non small cell lung

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD

MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD MADIT Studies: CRT in the Non-LBBB Patient and Other Findings Arthur J. Moss, MD University of Rochester Medical Cntr. Rochester, NY 13 th Annual New Frontiers in Heart Failure Rx NYC, NY January 26, 2013

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Caldeira D, Canastro M, Barra M, et al. Risk of substantial intraocular bleeding with novel oral anticoagulants: systematic review and meta-analysis. JAMA Ophthalmol. Published

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Dodick DW, Silberstein SD, Bigal ME, et al. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA. doi:10.1001/jama.2018.4853

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals.

More information

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France

How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information Christophe Leclercq, MD,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.

More information

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure

Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

How do I convert my CRT Non Responder into Responder?

How do I convert my CRT Non Responder into Responder? How do I convert my CRT Non Responder into Responder? Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting Boston Scientific, Medtronic

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL Supplementary Figure 1. Recursive partitioning using PFS data in patients with advanced NSCLC with non-squamous histology treated in the placebo pemetrexed arm of LUME-Lung 2. (A)

More information

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia

Arbolishvili GN, Mareev VY Institute of Clinical Cardiology, Moscow, Russia THE VALUE OF 24 H HEART RATE VARIABILITY IN PREDICTING THE MODE OF DEATH IN PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION IN BETA-BLOCKING BLOCKING ERA Arbolishvili GN, Mareev VY Institute of Clinical

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant

More information

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J. Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter

More information

CRT-P or CRT-D From North Alberta to Nairobi

CRT-P or CRT-D From North Alberta to Nairobi CRT-P or CRT-D From North Alberta to Nairobi Dr Mzee Ngunga Aga Khan University Hospital Nairobi KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web:

More information